Press Releases and News
The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products. Our AQS3proTM was a cutting edge addition … “AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019”
RedShift™ BioAnalytics, Inc. (RedShiftBio™) announces that the AQS3pro has been named as a finalist in the Prism Awards 2019. The Prism Awards recognize outstanding examples and innovative products that are changing lives for the better. This year was quoted by one of the judges to be “an exceptional year of exceptional products”.
Spurred by manufacturing advancements over the past decade, lasers, sensors, and imaging devices have become more compact and reliable. This progress has allowed spectroscopy to grow into new and diverse fields.
RedShift™ BioAnalytics, Inc. (RedShiftBio™) announces that the AQS3pro has won a 2018 TASIA (‘The Analytical Scientist Innovation Award’).
At the inaugural AAPS PharmSci 360 meeting (Washington, DC, Nov 4 – 7) RedShift™ BioAnalytics, Inc. (RedShiftBio™) will be highlighting collaborative studies with leading biopharmaceutical companies that demonstrate the industrial value and relevance of the recently launched AQS3pro
The ability of antibody-drug conjugates (ADCs) to deliver targeted chemotherapeutic drugs makes this relatively new class of biopharmaceutical drugs the subject of intense drug development activity, most notably for cancer treatment.
Biopharm International interviews scientists with experience of Microfluidic Modulation Spectroscopy for a round-table on how complex protein studies demand dynamic techniques. Visit page 18 to see what Immunogen, Janssen, Elion Labs and the University of Delaware have to say.
Our team recently joined international bioprocess professionals at the Bioprocessing Summit, where we discussed practical solutions for bioprocess challenges. Karan Shah, Principal Development Associate, Analytical and Pharmaceutical Sciences, ImmunoGen, gave a great talk on our Modulation Spectrometry (MMS) technique. He presented a comparison of his MMS results with conventional analytical approaches. If you are interested … “Immunogen presents MMS data in talk at Bioprocessing Summit”
The RedShiftBio team has just returned from Colorado where we attended a great workshop on aggregation and immunogenicity. Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding the role of aggregates during immunogenicity of therapeutic protein products is critical, and therefore was the Workshop focus. Our AQS3pro … “Workshop on Protein Aggregation and Immunogenicity in Colorado”
Valerie Ivancic has joined the team as an Applications Scientist. She brings experience in the biophysical characterization of amyloid proteins and aggregation: key applications for many users of the Microfluidic Modulation Spectroscopy (MMS)-based AQS3pro.